Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-17 4:23 pm Sale | 2023-11-08 | 13G | EQRx, Inc. EQRX | ARCH Venture Fund X L.P. | 0 0.000% | -36,335,375 (Position Closed) | Filing History |
| 2023-11-17 06:00 am Sale | 2023-11-09 | 13D | EQRx, Inc. EQRX | AH Bio Fund II L.P. | 0 0.000% | -53,064,157 (Position Closed) | Filing History |
| 2023-11-15 5:27 pm Unchanged | 2023-11-09 | 13D | EQRx, Inc. EQRX | Andreessen Horowitz Fund I L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-11-14 6:35 pm Sale | 2023-11-09 | 13D | EQRx, Inc. EQRX | Casdin Capital LLC | 0 0.000% | -56,297,042 (Position Closed) | Filing History |
| 2023-02-09 11:19 am Purchase | 2022-12-30 | 13G | EQRx, Inc. EQRX | VANGUARD GROUP INC | 25,952,741 5.310% | 25,952,741 (New Position) | Filing History |
| 2023-01-18 5:17 pm Purchase | 2023-01-17 | 13D | EQRx, Inc. EQRX | SOFTBANK GROUP CORP | 21,800,000 4.500% | 21,800,000 (New Position) | Filing History |
| 2022-11-29 5:11 pm Purchase | 2022-11-23 | 13D | EQRx, Inc. EQRX | Casdin Capital LLC | 56,297,042 13.000% | 56,297,042 (New Position) | Filing History |
| 2022-02-14 12:36 pm Purchase | 2021-12-31 | 13G | EQRx, Inc. EQRX | GV 2019 L.P. | 47,252,687 9.690% | 47,252,687 (New Position) | Filing History |
| 2022-02-14 06:28 am Purchase | 2021-12-31 | 13G | EQRx, Inc. EQRX | CITADEL ADVISORS LLC | 113,326 0.000% | 113,326 (New Position) | Filing History |
| 2022-02-11 4:57 pm Purchase | 2021-12-31 | 13G | EQRx, Inc. EQRX | ARCH Venture Fund X L.P. | 36,335,375 7.500% | 36,335,375 (New Position) | Filing History |
| 2021-12-29 6:26 pm Purchase | 2021-12-17 | 13D | CM Life Sciences III Inc. CMLT | Casdin Eli | 56,297,042 13.000% | 56,297,042 (New Position) | Filing History |
| 2021-12-27 4:31 pm Purchase | 2021-12-17 | 13D | EQRx, Inc. EQRX | AH Bio Fund II L.P. | 53,064,157 10.900% | 53,064,157 (New Position) | Filing History |
| 2021-12-27 4:15 pm Purchase | 2021-12-17 | 13D | EQRx, Inc. EQRX | SB Management Ltd | 43,976,000 9.000% | 43,976,000 (New Position) | Filing History |
| 2021-12-10 4:41 pm Purchase | 2021-11-30 | 13G | CM Life Sciences III Inc. CMLT | CITADEL ADVISORS LLC | 2,342,723 4.200% | 2,342,723 (New Position) | Filing History |